Our identification of NUAK2 but not NUAK1 in the TNBC lines, an observation we confirmed in separate studies [23], suggests that NUAK2, rather than NUAK1, may play a more prominent role in promoting YAP/TAZ activity in breast cancer. This evidence concerns the gene NUAK2 and breast carcinoma.